Indoco Grows By Over A Fifth
Indian Firm Waits For ANDA Approvals After FDA Inspection
Indoco has reported 21% sales growth in its financial second quarter and is awaiting a string of ANDA approvals after successfully completing FDA inspections of a Goa steriles plant and its Hyderabad-based clinical research organization. However, an FDA warning letter hangs over another facility.
